Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMC 2225989)

Published in Vaccine on November 20, 2007

Authors

Ralph LeBlanc1, Yessika Vasquez, Drew Hannaman, Nirbhay Kumar

Author Affiliations

1: Johns Hopkins Malaria Research Institute, Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.

Associated clinical trials:

Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation | NCT00471133

V930 First in Man (FIM) Study (V930-002)(COMPLETED) | NCT00250419

Articles citing this

Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol (2011) 2.25

Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine (2009) 1.38

The IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species. Vaccine (2010) 1.17

Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults. Mol Ther (2009) 1.05

A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity. PLoS One (2011) 1.05

Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding. Infect Immun (2014) 0.96

Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons. Vaccine (2013) 0.87

Plasmid injection and application of electric pulses alter endogenous mRNA and protein expression in B16.F10 mouse melanomas. Cancer Gene Ther (2010) 0.85

Characterization of human papillomavirus type 11-specific immune responses in a preclinical model. Laryngoscope (2010) 0.81

Evaluation of the Impact of Codon Optimization and N-Linked Glycosylation on Functional Immunogenicity of Pfs25 DNA Vaccines Delivered by In Vivo Electroporation in Preclinical Studies in Mice. Clin Vaccine Immunol (2015) 0.78

Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation. Vaccine (2016) 0.75

Malaria-Infected Mice Are Cured by a Single Low Dose of a New Silylamide Trioxane Plus Mefloquine. Pharmaceuticals (Basel) (2009) 0.75

Impact of the Charge Ratio on the In Vivo Immunogenicity of Lipoplexes. Pharm Res (2017) 0.75

Articles cited by this

The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (2005) 31.73

Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature (1981) 3.88

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature (1988) 3.31

Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods (1986) 3.07

DNA vaccines: progress and challenges. J Immunol (2005) 2.34

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine (2005) 2.21

Transmission blocking malaria vaccines. Vaccine (2001) 1.96

Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. Infect Immun (1994) 1.87

Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol (2007) 1.87

Commitment of the malaria parasite Plasmodium falciparum to sexual and asexual development. Parasitology (1990) 1.82

Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine (2004) 1.74

Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials. Vaccine (2003) 1.43

Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine (2005) 1.37

Human clinical trials of plasmid DNA vaccines. Adv Genet (2005) 1.35

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. Proc Natl Acad Sci U S A (2004) 1.31

Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer. Malar J (2007) 1.29

Enhancement of immune responses to an HBV DNA vaccine by electroporation. Vaccine (2005) 1.27

Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trials. Protein Expr Purif (2002) 1.23

Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies. Infect Immun (1999) 1.16

Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations. Infect Immun (2004) 1.14

Current developments in malaria transmission-blocking vaccines. Expert Opin Biol Ther (2001) 1.11

A novel electroporation device for gene delivery in large animals and humans. Vaccine (2005) 1.09

Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity. Vaccine (2006) 1.05

Genetic adjuvants for DNA vaccines. Vaccine (2001) 1.05

Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection. Vaccine (2004) 1.04

Microparticles for the delivery of DNA vaccines. Immunol Rev (2004) 1.04

Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation. Vaccine (2007) 1.00

Adjuvant formulations and delivery systems for DNA vaccines. Methods (2003) 1.00

DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates. Vaccine (2005) 0.99

A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months. Vaccine (2007) 0.98

Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy. Vaccine (2004) 0.95

Successful parallel development and integration of a plasmid-based biologic, container/closure system and electrokinetic delivery device. Vaccine (2005) 0.94

Engineering of needle-free physical methods to target epidermal cells for DNA vaccination. Vaccine (2005) 0.88

Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles. Vaccine (2004) 0.87

Vaxfectin enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines. Vaccine (2005) 0.80

Articles by these authors

Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med (2005) 3.85

Detection of Plasmodium falciparum in pregnancy by laser desorption mass spectrometry. Am J Trop Med Hyg (2005) 1.81

In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS One (2011) 1.71

The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J Clin Invest (2008) 1.59

A filter paper method for the detection of Plasmodium falciparum gametocytes by reverse transcription polymerase chain reaction. Am J Trop Med Hyg (2008) 1.54

Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice. Vaccine (2010) 1.54

Short report: modulation of Mycobacterium tuberculosis infection by Plasmodium in the murine model. Am J Trop Med Hyg (2004) 1.54

Electroporation-based DNA immunisation: translation to the clinic. Expert Opin Biol Ther (2007) 1.52

A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli. PLoS One (2009) 1.51

Genome annotation of Anopheles gambiae using mass spectrometry-derived data. BMC Genomics (2005) 1.51

Malaria parasite invasion of the mosquito salivary gland requires interaction between the Plasmodium TRAP and the Anopheles saglin proteins. PLoS Pathog (2009) 1.44

Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine (2009) 1.38

Knowledge attitudes and practices of grade three primary schoolchildren in relation to schistosomiasis, soil transmitted helminthiasis and malaria in Zimbabwe. BMC Infect Dis (2011) 1.21

Aquaporin 9 is the major pathway for glycerol uptake by mouse erythrocytes, with implications for malarial virulence. Proc Natl Acad Sci U S A (2007) 1.18

Involvement of gonadal steroids and gamma interferon in sex differences in response to blood-stage malaria infection. Infect Immun (2006) 1.15

A proteogenomic analysis of Anopheles gambiae using high-resolution Fourier transform mass spectrometry. Genome Res (2011) 1.14

Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations. Infect Immun (2004) 1.14

Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine. Infect Immun (2002) 1.13

Aquaglyceroporin PbAQP during intraerythrocytic development of the malaria parasite Plasmodium berghei. Proc Natl Acad Sci U S A (2007) 1.13

Infection with parasitic nematodes confounds vaccination efficacy. Vet Parasitol (2007) 1.10

Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine. Cancer Immunol Immunother (2012) 1.10

Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine (2009) 1.09

Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice. Vaccine (2009) 1.06

Transdermal Diagnosis of Malaria Using Vapor Nanobubbles. Emerg Infect Dis (2015) 1.06

A proteomic analysis of salivary glands of female Anopheles gambiae mosquito. Proteomics (2005) 1.05

Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization. Malar J (2009) 1.04

HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques. Vaccine (2013) 1.03

Impact of schistosome infection on Plasmodium falciparum Malariometric indices and immune correlates in school age children in Burma Valley, Zimbabwe. PLoS Negl Trop Dis (2010) 1.02

Structure of a gametocyte protein essential for sexual development in Plasmodium falciparum. Nat Struct Biol (2003) 1.01

Comparative analysis of the diagnostic performance of six major Echinococcus granulosus antigens assessed in a double-blind, randomized multicenter study. J Clin Microbiol (2005) 1.01

Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25. Infect Immun (2008) 1.01

A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates. Clin Vaccine Immunol (2011) 0.99

Rapid detection of malaria infection in vivo by laser desorption mass spectrometry. Am J Trop Med Hyg (2004) 0.98

Molecular players of homologous recombination in protozoan parasites: implications for generating antigenic variation. Infect Genet Evol (2004) 0.97

Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo. Chem Biol (2009) 0.97

Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen. Vaccine (2010) 0.97

Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding. Infect Immun (2014) 0.96

Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy. Vaccine (2004) 0.95

A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4β7-binding V2 loop of HIV gp120 in healthy volunteers. Clin Vaccine Immunol (2012) 0.93

Phase I/II evaluation of the prophylactic antimalarial activity of pafuramidine in healthy volunteers challenged with Plasmodium falciparum sporozoites. Am J Trop Med Hyg (2009) 0.93

Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen. Infect Immun (2004) 0.92

Identification and molecular characterisation of DNA damaging agent induced expression of Plasmodium falciparum recombination protein PfRad51. Int J Parasitol (2003) 0.92

Centrins, cell cycle regulation proteins in human malaria parasite Plasmodium falciparum. J Biol Chem (2008) 0.92

Exacerbation of Plasmodium yoelii malaria in Echinostoma caproni infected mice and abatement through anthelmintic treatment. J Parasitol (2005) 0.92

Critical role of a K+ channel in Plasmodium berghei transmission revealed by targeted gene disruption. Proc Natl Acad Sci U S A (2008) 0.92

Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific. Infect Immun (2005) 0.90

Delivery of a DNA vaccine for Alzheimer's disease by electroporation versus gene gun generates potent and similar immune responses. Neurodegener Dis (2012) 0.90

Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation. Vaccine (2010) 0.90

Antibody responses to Plasmodium falciparum vaccine candidate antigens in three areas distinct with respect to altitude. Acta Trop (2006) 0.90

A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge. Hum Vaccin Immunother (2012) 0.90

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells. Cell Biosci (2014) 0.90

Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens. Vaccine (2008) 0.89

Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model. Exp Parasitol (2009) 0.89

Extra terminal residues have a profound effect on the folding and solubility of a Plasmodium falciparum sexual stage-specific protein over-expressed in Escherichia coli. Eur J Biochem (2002) 0.88

A single electroporation delivery of a DNA vaccine containing the hemagglutinin gene of Asian H5N1 avian influenza virus generated a protective antibody response in chickens against a North American virus strain. Clin Vaccine Immunol (2013) 0.88

Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons. Vaccine (2013) 0.87

Immunogenicity of DNA vaccines encoding simian immunodeficiency virus antigen targeted to dendritic cells in rhesus macaques. PLoS One (2012) 0.87

Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges. Hum Vaccin Immunother (2015) 0.86

A modified Plasmodium falciparum growth inhibition assay (GIA) to assess activity of plasma from malaria endemic areas. Exp Parasitol (2006) 0.85

Gene-based intramuscular interferon-beta therapy for experimental autoimmune encephalomyelitis. Mol Ther (2006) 0.85

Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies. Vaccine (2010) 0.85

High prevalence of molecular markers for resistance to chloroquine and pyrimethamine in Plasmodium falciparum from Zimbabwe. Parasitol Res (2007) 0.85

Optimization of a Der p 2-based prophylactic DNA vaccine against house dust mite allergy. Immunol Lett (2013) 0.85

Functional analysis of Plasmodium falciparum parasitophorous vacuole membrane protein (Pfs16) during gametocytogenesis and gametogenesis by targeted gene disruption. Mol Biochem Parasitol (2004) 0.84

Enhanced malaria parasite transmission from helminth co-infected mice. Am J Trop Med Hyg (2007) 0.84

Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors. J Leukoc Biol (2005) 0.84

Host microsatellite alleles in malaria predisposition? Malar J (2005) 0.83

Counter-regulatory anti-parasite cytokine responses during concurrent Plasmodium yoelii and intestinal helminth infections in mice. Exp Parasitol (2008) 0.83

Plasmodium falciparum protein phosphatase type 1 functionally complements a glc7 mutant in Saccharomyces cerevisiae. Int J Parasitol (2002) 0.83

Opposing roles for two molecular forms of replication protein A in Rad51-Rad54-mediated DNA recombination in Plasmodium falciparum. MBio (2013) 0.83

Characterization of kinetics of DNA strand-exchange and ATP hydrolysis activities of recombinant PfRad51, a Plasmodium falciparum recombinase. Mol Biochem Parasitol (2005) 0.83

Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks. J Virol (2011) 0.82

Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primates. J Virol (2014) 0.82

Protective efficacy and immunogenicity of a combinatory DNA vaccine against Influenza A Virus and the Respiratory Syncytial Virus. PLoS One (2013) 0.82

Antimalarial Preclinical Drug Development: A Single Oral Dose of A 5-Carbon-linked Trioxane Dimer Plus Mefloquine Cures Malaria-Infected Mice. Drug Dev Res (2009) 0.82

A compendium of molecules involved in vector-pathogen interactions pertaining to malaria. Malar J (2013) 0.81

Functional characterisation of sexual stage specific proteins in Plasmodium falciparum. Int J Parasitol (2002) 0.81

Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccines. Eukaryot Cell (2008) 0.81

Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation. Virology (2012) 0.81

A chemiluminescent-western blot assay for quantitative detection of Plasmodium falciparum circumsporozoite protein. J Immunol Methods (2013) 0.80

Translocation of ribosomal protein P0 onto the Toxoplasma gondii tachyzoite surface. Int J Parasitol (2003) 0.80

Brain proteomics of Anopheles gambiae. OMICS (2014) 0.79

Two doses of bovine viral diarrhea virus DNA vaccine delivered by electroporation induce long-term protective immune responses. Clin Vaccine Immunol (2012) 0.79

Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum. J Biol Chem (2013) 0.79

Novel nanosomes for gene delivery to Plasmodium falciparum-infected red blood cells. Sci Rep (2013) 0.79

Aberrant sporogonic development of Dmc1 (a meiotic recombinase) deficient Plasmodium berghei parasites. PLoS One (2012) 0.78

Detection and species identification of malaria parasites by isothermal tHDA amplification directly from human blood without sample preparation. J Mol Diagn (2013) 0.78

Efficacy of integrated school based de-worming and prompt malaria treatment on helminths -Plasmodium falciparum co-infections: A 33 months follow up study. BMC Int Health Hum Rights (2011) 0.78

Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague. Vaccine (2012) 0.78

Analysis of genetic polymorphism in select vaccine candidate antigens and microsatellite loci in Plasmodium falciparum from endemic areas at varying altitudes. Acta Trop (2007) 0.78

Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscle. Curr Gene Ther (2015) 0.77

Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45. Infect Immun (2006) 0.77

In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins. Virology (2012) 0.77

DNA electroporation of multi-agent vaccines conferring protection against select agent challenge: TriGrid delivery system. Methods Mol Biol (2014) 0.77

Transdermal Diagnosis of Malaria Using Vapor Nanobubbles. Emerg Infect Dis (2016) 0.75

Optimization of the immunogenicity of a DNA vaccine encoding a bacterial outer membrane lipoprotein. Mol Biotechnol (2014) 0.75

Expression, purification, crystallization and preliminary X-ray analysis of the sexual stage-specific protein Pfg27 from Plasmodium falciparum. Acta Crystallogr D Biol Crystallogr (2002) 0.75

Effect of probenecid on kinetics of enrofloxacin in lactating goats after subcutaneous administration. Indian J Exp Biol (2009) 0.75